-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
In -X- _ O
malaria-endemic -X- _ O
areas -X- _ O
, -X- _ O
human -X- _ O
populations -X- _ O
are -X- _ O
frequently -X- _ O
exposed -X- _ O
to -X- _ O
immunomodulatory -X- _ O
salivary -X- _ O
components -X- _ O
injected -X- _ O
during -X- _ O
mosquito -X- _ O
blood -X- _ O
feeding. -X- _ O
The -X- _ O
consequences -X- _ O
on -X- _ O
pathogen-specific -X- _ O
immune -X- _ O
responses -X- _ O
are -X- _ O
not -X- _ O
well -X- _ O
known. -X- _ O
This -X- _ O
study -X- _ O
evaluated -X- _ O
and -X- _ O
compared -X- _ O
the -X- _ O
humoral -X- _ B-Outcome
responses -X- _ I-Outcome
specific -X- _ I-Outcome
to -X- _ I-Outcome
merozoite -X- _ I-Outcome
stage -X- _ I-Outcome
vaccine -X- _ I-Outcome
candidates -X- _ I-Outcome
of -X- _ I-Outcome
Plasmodium -X- _ I-Outcome
falciparum -X- _ I-Outcome
, -X- _ O
in -X- _ O
children -X- _ O
differentially -X- _ O
exposed -X- _ O
to -X- _ O
Anopheles -X- _ B-Intervention
bites -X- _ I-Intervention
in -X- _ O
a -X- _ O
natural -X- _ O
setting. -X- _ O
METHODS -X- _ O
: -X- _ O
The -X- _ O
cross-sectional -X- _ O
study -X- _ O
was -X- _ O
carried -X- _ O
out -X- _ O
in -X- _ O
Bouaké -X- _ O
( -X- _ O
Côte -X- _ O
d’Ivoire -X- _ O
) -X- _ O
where -X- _ O
entomological -X- _ O
data -X- _ O
and -X- _ O
blood -X- _ O
samples -X- _ O
from -X- _ O
children -X- _ B-Patient
( -X- _ I-Patient
0–14 -X- _ I-Patient
years -X- _ I-Patient
) -X- _ I-Patient
were -X- _ O
collected -X- _ O
in -X- _ O
two -X- _ O
sites -X- _ O
with -X- _ O
similar -X- _ O
malaria -X- _ O
prevalence. -X- _ O
Antibody -X- _ O
( -X- _ O
IgG -X- _ O
, -X- _ O
IgG1 -X- _ O
, -X- _ O
IgG3 -X- _ O
) -X- _ O
responses -X- _ O
to -X- _ O
PfAMA1 -X- _ B-Comparison
and -X- _ I-Comparison
PfMSP1 -X- _ I-Comparison
were -X- _ O
evaluated -X- _ O
by -X- _ O
ELISA. -X- _ O
Univariate -X- _ O
and -X- _ O
multivariate -X- _ O
analysis -X- _ O
were -X- _ O
performed -X- _ O
to -X- _ O
assess -X- _ O
the -X- _ O
relationship -X- _ O
between -X- _ O
the -X- _ O
immune -X- _ O
responses -X- _ O
to -X- _ O
P. -X- _ O
falciparum -X- _ O
antigens -X- _ O
and -X- _ O
exposure -X- _ O
to -X- _ O
Anopheles -X- _ B-Intervention
bites -X- _ I-Intervention
in -X- _ O
the -X- _ O
total -X- _ O
cohort -X- _ O
and -X- _ O
in -X- _ O
each -X- _ O
site -X- _ O
, -X- _ O
separately. -X- _ O
The -X- _ O
individual -X- _ O
level -X- _ O
of -X- _ O
exposure -X- _ O
to -X- _ O
Anopheles -X- _ B-Intervention
bites -X- _ I-Intervention
was -X- _ O
evaluated -X- _ O
by -X- _ O
quantifying -X- _ O
specific -X- _ O
IgG -X- _ O
response -X- _ O
to -X- _ O
the -X- _ O
Anopheles -X- _ O
gSG6-P1 -X- _ O
salivary -X- _ O
peptide -X- _ O
, -X- _ O
which -X- _ O
represents -X- _ O
a -X- _ O
proxy -X- _ O
of -X- _ O
Anopheles -X- _ O
exposure. -X- _ O
RESULTS -X- _ O
: -X- _ O
The -X- _ O
anti-Plasmodium -X- _ O
humoral -X- _ O
responses -X- _ O
were -X- _ O
different -X- _ O
according -X- _ O
to -X- _ O
the -X- _ O
level -X- _ O
of -X- _ O
exposure -X- _ O
of -X- _ O
children -X- _ O
, -X- _ O
with -X- _ O
those -X- _ O
highly -X- _ O
exposed -X- _ O
to -X- _ O
Anopheles -X- _ O
presenting -X- _ O
significantly -X- _ O
lower -X- _ O
antibody -X- _ O
responses -X- _ O
to -X- _ O
PfMSP1 -X- _ O
in -X- _ O
total -X- _ O
population -X- _ O
( -X- _ O
IgG -X- _ O
and -X- _ O
IgG3 -X- _ O
) -X- _ O
and -X- _ O
in -X- _ O
Petessou -X- _ O
village -X- _ O
( -X- _ O
IgG -X- _ O
, -X- _ O
IgG1 -X- _ O
, -X- _ O
IgG3 -X- _ O
) -X- _ O
. -X- _ O
No -X- _ O
significant -X- _ O
difference -X- _ O
was -X- _ O
seen -X- _ O
for -X- _ O
PfAMA1 -X- _ O
antigen -X- _ O
between -X- _ O
children -X- _ O
differently -X- _ O
exposed -X- _ O
to -X- _ O
Anopheles. -X- _ O
In -X- _ O
Dar-es-Salam -X- _ O
, -X- _ O
a -X- _ O
neighbourhood -X- _ O
where -X- _ O
a -X- _ O
high -X- _ O
Culex -X- _ O
density -X- _ O
was -X- _ O
reported -X- _ O
, -X- _ O
children -X- _ O
presented -X- _ O
very -X- _ O
low -X- _ O
antibody -X- _ O
levels -X- _ O
specific -X- _ O
to -X- _ O
both -X- _ O
antigens -X- _ O
, -X- _ O
and -X- _ O
no -X- _ O
difference -X- _ O
according -X- _ O
to -X- _ O
the -X- _ O
exposure -X- _ O
to -X- _ O
Anopheles -X- _ B-Intervention
bites -X- _ I-Intervention
was -X- _ O
found. -X- _ O
CONCLUSION -X- _ O
: -X- _ O
These -X- _ O
findings -X- _ O
may -X- _ O
suggest -X- _ O
that -X- _ O
immunomodulatory -X- _ O
components -X- _ O
of -X- _ O
Anopheles -X- _ O
saliva -X- _ O
, -X- _ O
in -X- _ O
addition -X- _ O
to -X- _ O
other -X- _ O
factors -X- _ O
, -X- _ O
may -X- _ O
participate -X- _ O
to -X- _ O
the -X- _ O
modulation -X- _ O
of -X- _ O
the -X- _ O
humoral -X- _ O
response -X- _ O
specific -X- _ O
to -X- _ O
Plasmodium -X- _ O
merozoite -X- _ O
stage -X- _ O
antigens. -X- _ O
This -X- _ O
epidemiological -X- _ O
observation -X- _ O
may -X- _ O
form -X- _ O
a -X- _ O
starting -X- _ O
point -X- _ O
for -X- _ O
additional -X- _ O
work -X- _ O
to -X- _ O
decipher -X- _ O
the -X- _ O
role -X- _ O
of -X- _ O
mosquito -X- _ O
saliva -X- _ O
on -X- _ O
the -X- _ O
modulation -X- _ O
of -X- _ O
the -X- _ O
anti-Plasmodium -X- _ O
acquired -X- _ O
immunity -X- _ O
and -X- _ O
clinical -X- _ O
protection -X- _ O
in -X- _ O
combining -X- _ O
both -X- _ O
field -X- _ O
and -X- _ O
ex -X- _ O
vivo -X- _ O
immunological -X- _ O
studies -X- _ O
. -X- _ O

